258MO Niraparib Plus Abiraterone Acetate Plus Prednisone (NIRA+AAP) As First-Line Treatment in Patients with BRCA+ Metastatic Castration-Resistant Prostate Cancer (mcrpc): Second Interim Analysis in the Asian Subgroup of the MAGNITUDE Study

M. Saad,K. N. Chi,S. K. Sandhu,G. Attard,D. Ye, L. Li, W. Jung,S-T. Pang, P. S. J. Francis,S. Li,S. Dibaj, J. Zhang, W. Kim,A. Lopez-Gitlitz, D. Wu, A. Singh,R. De Vries, L. Zhang, J. Y. Lee

Annals of oncology（2023）

Cited 0|Views37

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined